End-Stage Renal Disease (ESRD) Treatment Market is segmented By Treatment Modality (Hemodialysis, Pe...
Market Size in USD Bn
CAGR5.4%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 5.4% |
Market Concentration | High |
Major Players | Fresenius Medical Care, DaVita Inc., Baxter International Inc., Nipro Corporation, B. Braun Melsungen AG and Among Others |
The end-stage renal disease (ESRD) treatment market is estimated to be valued at USD 89.27 Bn in 2025 and is expected to reach USD 129.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2032. The aging population and growing prevalence of chronic kidney diseases around the world is expected to propel the demand for ESRD treatment in the forecast period.